Browsing by Author "Lokhnygina, Yuliya"
Now showing items 1-9 of 9
-
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.
Stanifer, John W; Charytan, David M; White, Jennifer; Lokhnygina, Yuliya; Cannon, Christopher P; Roe, Matthew T; Blazing, Michael A (J Am Soc Nephrol, 2017-10)Efficacy of statin-based therapies in reducing cardiovascular mortality in individuals with CKD seems to diminish as eGFR declines. The strongest evidence supporting the cardiovascular benefit of statins in individuals with ... -
Body image and body satisfaction differ by race in overweight postpartum mothers.
Carter-Edwards, Lori; Bastian, Lori A; Revels, Jessica; Durham, Holiday; Lokhnygina, Yuliya; Amamoo, M Ahinee; Ostbye, Truls (J Womens Health (Larchmt), 2010-02)BACKGROUND: Body image (BI) and body satisfaction may be important in understanding weight loss behaviors, particularly during the postpartum period. We assessed these constructs among African American and white overweight ... -
Early recognition and response to increases in surgical site infections using optimised statistical process control charts-The early 2RIS trial: A multicentre stepped wedge cluster randomised controlled trial.
Baker, Arthur W; Ilieş, Iulian; Benneyan, James C; Lokhnygina, Yuliya; Foy, Katherine R; Lewis, Sarah S; Wood, Brittain; ... (22 authors) (EClinicalMedicine, 2022-12)<h4>Background</h4>Traditional approaches for surgical site infection (SSI) surveillance have deficiencies that delay detection of SSI outbreaks and other clinically important increases in SSI rates. We investigated whether ... -
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.
Mentz, Robert J; Bethel, M Angelyn; Merrill, Peter; Lokhnygina, Yuliya; Buse, John B; Chan, Juliana C; Felício, João S; ... (21 authors) (Journal of the American Heart Association, 2018-10)Background In the EXSCEL (Exenatide Study of Cardiovascular Event Lowering), exenatide once-weekly resulted in a nonsignificant reduction in major adverse cardiovascular events ( MACEs ) and a nominal 14% reduction in all-cause ... -
Harvesting the Low Hanging Fruit: A Benchmarking Tool for Implementation of Intravenous to Oral Antibiotic Switch Programs in 14 Southeastern Community Hospitals.
Garner, Bronwen; Lokhnygina, Yuliya; Dodds-Ashley, Elizabeth; Johnson, Melissa; Drew, Richard H; Davis, Angelina; Sexton, Daniel J; ... (9 authors) (Open forum infectious diseases, 2015-12-09) -
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.
Lopes, Renato D; Lokhnygina, Yuliya; Hasselblad, Victor; Newby, Kristin L; Yow, Eric; Granger, Christopher B; Armstrong, Paul W; ... (11 authors) (Trials, 2013-05-02)BACKGROUND: Larger infarct size measured by creatine kinase (CK)-MB release is associated with higher mortality and has been used as an important surrogate endpoint in the evaluation of new treatments for ST-segment elevation ... -
Myocardial Ischemia on Exercise Stress Echocardiography Testing Is Not Associated with Changes in Troponin T Concentrations
Limkakeng, Alexander T; Drake, Weiying; Lokhnygina, Yuliya; Meyers, Harvey P; Shogilev, Daniel; Christenson, Robert H; Newby, L Kristin (The Journal of Applied Laboratory Medicine, 2017)Background: Some posit that any amount of myocardial ischemia can be detected by high-sensitivity cardiac troponin assays. We hypothesized that patients with myocardial ischemia induced by exercise stress would have significantly ... -
Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide.
Limkakeng, Alexander T; Leahy, J Clancy; Griffin, S Michelle; Lokhnygina, Yuliya; Jaffa, Elias; Christenson, Robert H; Newby, L Kristin (Open Heart, 2018-01)Objective:Stress testing is commonly performed in emergency department (ED) patients with suspected acute coronary syndrome (ACS). We hypothesised that changes in N-terminal pro-B type natriuretic peptide (NT-proBNP) ... -
Treatment-related biomarkers in pulmonary hypertension patients on oral therapies.
Swaminathan, Aparna C; Zhu, Hongmei; Tapson, Victor; Lokhnygina, Yuliya; Poms, Abby; Kelleher, Zach; Gaspard, Elijah; ... (13 authors) (Respiratory research, 2020-11-19)<h4>Background</h4>Multiple classes of oral therapy are available for the treatment of pulmonary arterial hypertension (PAH), but there is little to guide clinicians in choosing a specific regimen or therapeutic class. We ...